Volume 71, Issue 1, Pages 1-3 (January 2017)

Slides:



Advertisements
Similar presentations
Volume 68, Issue 6, Pages (December 2015)
Advertisements

The PSA Era is not Over for Prostate Cancer
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
Volume 60, Issue 2, Pages (August 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Testosterone Therapy in Men With Prostate Cancer
Volume 68, Issue 6, Pages e129-e131 (December 2015)
Volume 61, Issue 6, Pages (June 2012)
Volume 74, Issue 2, Pages (August 2018)
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic.
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 69, Issue 1, Pages (January 2016)
Volume 68, Issue 2, Pages (August 2015)
Advances in the Treatment of Metastatic Prostate Cancer
Volume 52, Issue 3, Pages (September 2007)
Prostate Cancer Epidemic in Sight?
Volume 63, Issue 1, Pages (January 2013)
Volume 66, Issue 2, Pages (August 2014)
Volume 74, Issue 1, Pages (July 2018)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate.
Volume 65, Issue 3, Pages (March 2014)
Volume 65, Issue 1, Pages (January 2014)
Androgen Receptor Variants and Castration-resistant Prostate Cancer: Looking Back and Looking Forward  Takuma Uo, Cynthia Sprenger  European Urology 
Volume 67, Issue 2, Pages (February 2015)
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Prostate Cancer Detection: A View of the Future
Volume 70, Issue 5, Pages (November 2016)
Volume 66, Issue 3, Pages (September 2014)
Counselling the Prostate Cancer Patient
Laurent Boccon-Gibod  European Urology Supplements 
Volume 64, Issue 6, Pages (December 2013)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 70, Issue 1, Pages e27-e28 (July 2016)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Volume 72, Issue 1, Pages (July 2017)
Volume 66, Issue 2, Pages (August 2014)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Volume 74, Issue 2, Pages (August 2018)
The Economic Costs of Overactive Bladder in Germany
Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.
Volume 50, Issue 5, Pages (November 2006)
Volume 53, Issue 6, Pages (June 2008)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 71, Issue 6, Pages (June 2017)
Volume 55, Issue 6, Pages (June 2009)
Volume 53, Issue 1, Pages (January 2008)
Volume 49, Issue 4, Pages (April 2006)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Long-Term Hormonal Therapy: Who Would Benefit?
Volume 70, Issue 1, Pages (July 2016)
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
European Urology is “Your” Journal
Thomas Steuber, Matthew Frank O'Brien, Hans Lilja  European Urology 
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Axel Heidenreich  European Urology Supplements 
Improving Flexibility and Quality of Life for Your Patients: A Must?
Highlighting Unmet Needs: Real Patients, Difficult Choices
Volume 53, Issue 6, Pages (June 2008)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Axel Heidenreich  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 71, Issue 1, Pages 1-3 (January 2017) Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer  Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, Konrad Steinestel, Martin Boegemann, Andres J. Schrader, Julie Steinestel  European Urology  Volume 71, Issue 1, Pages 1-3 (January 2017) DOI: 10.1016/j.eururo.2016.07.021 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Overview of prior and new therapies along with androgen receptor splice variant (AR-V7) to androgen receptor full length (AR-FL) ratio (%), prostate-specific antigen (PSA) response (%), and progression free survival (PFS; d) for the six AR-V7-positive patients experiencing benefit from next generation androgen deprivation therapy (ADT). European Urology 2017 71, 1-3DOI: (10.1016/j.eururo.2016.07.021) Copyright © 2016 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.